Algimantas Sruogis, Albertas Ulys, Giedre Smailyte, Zygimantas Kardelis, Arunas Kulboka, Giedre Anglickienė, Nerimantas Samalavicius, Marius Anglickis
{"title":"Incidentally found prostate cancer and influence on overall survival after radical cystoprostatectomy.","authors":"Algimantas Sruogis, Albertas Ulys, Giedre Smailyte, Zygimantas Kardelis, Arunas Kulboka, Giedre Anglickienė, Nerimantas Samalavicius, Marius Anglickis","doi":"10.1155/2012/690210","DOIUrl":null,"url":null,"abstract":"Objectives. To determine incidentally found prostate cancer frequency and impact on overall survival after RCP. Patients and Methods. The records of 81 men who underwent cystoprostatectomy from January 2000 to December 2009 were reviewed. The vital status of the study group was assessed as on September 1, 2009, by passive followup, using data from the population registry. Results. The 81 men underwent RCP. The incidental prostate cancer was found in the specimens of 27 (33.3%) patients. 13 (48.1%) of 27 prostate cancer cases were clinically significant. For 3 patients (11.1%) an extraprostatic extension was found. For 2 patients (7.4%)—positive margins, for 1 patient (3.7%)—Gleason sum 8, and for the rest 7 patients bigger than 0.5 cm3 volume tumor, and Gleason sum 7 was found. The mean follow-up time was 39.2 ± 33.8 months (varies from 0.8 to 131.2 months). The patients with bladder cancer and incidentally found prostate cancer lived shorter (28.1 ± 27.5 and 45.5 ± 35.40 months). Higher overall survival (P = 0.03) was found in the patient group with bladder cancer without incidentally diagnosed prostate cancer. Conclusion. There are indications that in this small study prostate cancer has influenced on patients' survival with bladder cancer after radical cystoprostatectomy.","PeriodicalId":20907,"journal":{"name":"Prostate Cancer","volume":"2012 ","pages":"690210"},"PeriodicalIF":2.3000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/690210","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostate Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2012/690210","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/6/3 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 14
Abstract
Objectives. To determine incidentally found prostate cancer frequency and impact on overall survival after RCP. Patients and Methods. The records of 81 men who underwent cystoprostatectomy from January 2000 to December 2009 were reviewed. The vital status of the study group was assessed as on September 1, 2009, by passive followup, using data from the population registry. Results. The 81 men underwent RCP. The incidental prostate cancer was found in the specimens of 27 (33.3%) patients. 13 (48.1%) of 27 prostate cancer cases were clinically significant. For 3 patients (11.1%) an extraprostatic extension was found. For 2 patients (7.4%)—positive margins, for 1 patient (3.7%)—Gleason sum 8, and for the rest 7 patients bigger than 0.5 cm3 volume tumor, and Gleason sum 7 was found. The mean follow-up time was 39.2 ± 33.8 months (varies from 0.8 to 131.2 months). The patients with bladder cancer and incidentally found prostate cancer lived shorter (28.1 ± 27.5 and 45.5 ± 35.40 months). Higher overall survival (P = 0.03) was found in the patient group with bladder cancer without incidentally diagnosed prostate cancer. Conclusion. There are indications that in this small study prostate cancer has influenced on patients' survival with bladder cancer after radical cystoprostatectomy.
目标。确定偶然发现前列腺癌的频率及其对RCP术后总生存率的影响。患者和方法。本文回顾了2000年1月至2009年12月行膀胱前列腺切除术的81例男性患者的记录。通过被动随访,使用人口登记处的数据,于2009年9月1日对研究组的生命状况进行评估。结果。81名男性接受了RCP。27例(33.3%)患者标本中发现偶发前列腺癌。27例前列腺癌中有13例(48.1%)具有临床意义。3例患者(11.1%)发现前列腺外展。2例(7.4%)边缘阳性,1例(3.7%)Gleason sum 8,其余7例肿瘤体积大于0.5 cm(3),并发现Gleason sum 7。平均随访时间39.2±33.8个月(0.8 ~ 131.2个月)。膀胱癌伴发前列腺癌患者生存时间较短,分别为28.1±27.5个月和45.5±35.40个月。膀胱癌患者的总生存率高于前列腺癌患者(P = 0.03)。结论。有迹象表明,在这项小型研究中,前列腺癌影响膀胱癌根治性膀胱前列腺切除术后患者的生存。
期刊介绍:
Prostate Cancer is a peer-reviewed, Open Access journal that provides a multidisciplinary platform for scientists, surgeons, oncologists and clinicians working on prostate cancer. The journal publishes original research articles, review articles, and clinical studies related to the diagnosis, surgery, radiotherapy, drug discovery and medical management of the disease.